| William Leppert, DO | |
|
12 St Paul Dr Ste 101, Chambersburg, PA 17201-1035 | |
| (717) 217-6760 | |
| (717) 217-6912 |
| Full Name | William Leppert |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 12 St Paul Dr Ste 101, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962508895 | NPI | - | NPPES |
| 103758990 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5101011951 (Michigan) | Secondary |
| 207Q00000X | Family Medicine | OS020418 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Home Health Care, Inc | Chambersburg, PA | Home health agency |
| Wellspan Vna Home Care | York, PA | Home health agency |
| Residential Home Health Of Carlisle, Llc | Mechanicsburg, PA | Home health agency |
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Waynesboro Hospital | Waynesboro, PA | Hospital |
| Menno Haven Rehabilitation Center | Chambersburg, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cora Health Services, Inc. | 1759290992 | 556 |
| Wellspan Medical Group | 1951213115 | 1946 |
| Summit Physician Services | 5496659484 | 353 |
News Archive
The Prescription Drug Monitoring Program Center of Excellence at Brandeis University has issued a ground-breaking report recommending that medical insurers use prescription monitoring data to reduce the overdoses, deaths and health care costs associated with abuse of opioids and other prescription drugs.
Contrary to the concerns of many HIV-infected patients, there appears to be no specific antiretroviral drug-related "syndrome" of changes in body fat distribution in men wherein leg and arm fat decrease as belly fat increases, reports a study in the October issue of Journal of Acquired Immune Deficiency Syndromes (JAIDS).
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
"Malnutrition is likely to be the most serious health threat linked to climate shifts in the coming decades, as farmers struggle to cope with more unpredictable weather, ... epidemiologist Kris Ebi warned during a recent World Health Organization (WHO) briefing on adapting health systems to climate shifts," AlertNet reports.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
› Verified 4 days ago
| Entity Name | Summit Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306840814 PECOS PAC ID: 5496659484 Enrollment ID: O20031121000259 |
News Archive
The Prescription Drug Monitoring Program Center of Excellence at Brandeis University has issued a ground-breaking report recommending that medical insurers use prescription monitoring data to reduce the overdoses, deaths and health care costs associated with abuse of opioids and other prescription drugs.
Contrary to the concerns of many HIV-infected patients, there appears to be no specific antiretroviral drug-related "syndrome" of changes in body fat distribution in men wherein leg and arm fat decrease as belly fat increases, reports a study in the October issue of Journal of Acquired Immune Deficiency Syndromes (JAIDS).
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
"Malnutrition is likely to be the most serious health threat linked to climate shifts in the coming decades, as farmers struggle to cope with more unpredictable weather, ... epidemiologist Kris Ebi warned during a recent World Health Organization (WHO) briefing on adapting health systems to climate shifts," AlertNet reports.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
› Verified 4 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
The Prescription Drug Monitoring Program Center of Excellence at Brandeis University has issued a ground-breaking report recommending that medical insurers use prescription monitoring data to reduce the overdoses, deaths and health care costs associated with abuse of opioids and other prescription drugs.
Contrary to the concerns of many HIV-infected patients, there appears to be no specific antiretroviral drug-related "syndrome" of changes in body fat distribution in men wherein leg and arm fat decrease as belly fat increases, reports a study in the October issue of Journal of Acquired Immune Deficiency Syndromes (JAIDS).
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
"Malnutrition is likely to be the most serious health threat linked to climate shifts in the coming decades, as farmers struggle to cope with more unpredictable weather, ... epidemiologist Kris Ebi warned during a recent World Health Organization (WHO) briefing on adapting health systems to climate shifts," AlertNet reports.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Leppert, DO 785 5th Ave Ste 3, Chambersburg, PA 17201-4232 Ph: (717) 263-9555 | William Leppert, DO 12 St Paul Dr Ste 101, Chambersburg, PA 17201-1035 Ph: (717) 217-6760 |
News Archive
The Prescription Drug Monitoring Program Center of Excellence at Brandeis University has issued a ground-breaking report recommending that medical insurers use prescription monitoring data to reduce the overdoses, deaths and health care costs associated with abuse of opioids and other prescription drugs.
Contrary to the concerns of many HIV-infected patients, there appears to be no specific antiretroviral drug-related "syndrome" of changes in body fat distribution in men wherein leg and arm fat decrease as belly fat increases, reports a study in the October issue of Journal of Acquired Immune Deficiency Syndromes (JAIDS).
The U.S. Government has proposed major changes in the rules covering research involving human subjects. Officials believe this would strengthen protections while reducing red tape that can impede studies. The experts cited vastly altered research climate as reasons for these recommendations. New features include genomics studies using patients' DNA samples, the use of the Internet and a growing reliance on studies that take place at many sites at once. The new rules cover topics like the informed consent that research participants must provide and the institutional review boards that oversee research at universities and hospitals.
"Malnutrition is likely to be the most serious health threat linked to climate shifts in the coming decades, as farmers struggle to cope with more unpredictable weather, ... epidemiologist Kris Ebi warned during a recent World Health Organization (WHO) briefing on adapting health systems to climate shifts," AlertNet reports.
Cylene Pharmaceuticals, Inc. has been selected to present data describing the activity of their first-in-class CK2 inhibitor at the 52nd Annual Meeting of the American Society of Hematology, to be held on December 4-7 in Orlando, FL, the company announced today. Kenna Anderes, VP Cancer Biology at Cylene, will discuss research on targeting CK2, a protein kinase that is essential for the progression of multiple myeloma but that has not been previously exploited as an anticancer target.
› Verified 4 days ago
Todd Victor Peterson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3208 Baltusrol Dr, Chambersburg, PA 17202 Phone: 717-860-0890 | |
James Raymond Owens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 5th Ave, Chambersburg, PA 17201 Phone: 717-709-7999 Fax: 717-263-6922 | |
Barbara Ann Haeckler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 5th Ave, Chambersburg, PA 17201 Phone: 717-263-4313 Fax: 717-263-0500 | |
Ashley Brooke Martin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12 St Paul Dr Ste 101, Chambersburg, PA 17201 Phone: 717-217-6760 Fax: 717-217-6912 | |
Jennifer P Chan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 5th Ave, Chambersburg, PA 17201 Phone: 717-263-4313 Fax: 717-263-0500 | |
Dr. Sheldon Lebovitz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 Phoenix Dr Ste A, Chambersburg, PA 17201 Phone: 717-264-6185 Fax: 717-264-8226 | |
Regina Thaddeus, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3106 Philadelphia Ave, Chambersburg, PA 17201 Phone: 717-264-3644 |